CT
BSX icon

Chicago Trust’s Boston Scientific BSX Stock Holding History

Chicago Trust’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.13M Sell
25,994
-10,070
-28% -$466K 0.15% 127
2026
Q2 		$1.54M Buy
36,064
+3,177
+10% +$173K 0.22% 95
2026
Q1 		$2.06M Buy
32,887
+3,009
+10% +$241K 0.33% 68
2025
Q4 		$2.85M Sell
29,878
-4,307
-13% -$422K 0.45% 48
2025
Q3 		$3.34M Buy
34,185
+1,757
+5% +$182K 0.46% 47
2025
Q2 		$3.48M Buy
32,428
+1,930
+6% +$195K 0.49% 41
2025
Q1 		$3.08M Sell
30,498
-379
-1% -$38.2K 0.55% 41
2024
Q4 		$2.76M Sell
30,877
-339
-1% -$29.8K 0.49% 43
2024
Q3 		$2.62M Buy
31,216
+1,777
+6% +$140K 0.45% 54
2024
Q2 		$2.27M Sell
29,439
-128
-0.4% -$9.37K 0.46% 54
2024
Q1 		$2.03M Sell
29,567
-248
-0.8% -$15.9K 0.42% 67
2023
Q4 		$1.72M Sell
29,815
-598
-2% -$31.9K 0.38% 63
2023
Q3 		$1.61M Buy
30,413
+370
+1% +$19.4K 0.4% 61
2023
Q2 		$1.63M Sell
30,043
-210
-0.7% -$11K 0.39% 66
2023
Q1 		$1.51M Sell
30,253
-9,983
-25% -$470K 0.38% 71
2022
Q4 		$1.86M Buy
40,236
+595
+2% +$25.8K 0.46% 57
2022
Q3 		$1.54M Sell
39,641
-1,145
-3% -$45.9K 0.4% 66
2022
Q2 		$1.52M Sell
40,786
-1,325
-3% -$53.9K 0.38% 71
2022
Q1 		$1.86M Sell
42,111
-2,065
-5% -$89.5K 0.4% 69
2021
Q4 		$1.88M Buy
44,176
+10,511
+31% +$442K 0.37% 75
2021
Q3 		$1.46M Buy
33,665
+398
+1% +$17.6K 0.32% 86
2021
Q2 		$1.42M Buy
33,267
+6,239
+23% +$262K 0.34% 86
2021
Q1 		$1.04M Buy
27,028
+1,275
+5% +$48.3K 0.36% 79
2020
Q4 		$926K Buy
25,753
+778
+3% +$28K 0.32% 90
2020
Q3 		$954K Buy
24,975
+5,561
+29% +$214K 0.4% 77
2020
Q2 		$682K Buy
19,414
+2,948
+18% +$106K 0.3% 94
2020
Q1 		$537K Buy
16,466
+932
+6% +$36.4K 0.27% 96
2019
Q4 		$702K Sell
15,534
-70
-0.4% -$2.93K 0.29% 94
2019
Q3 		$635K Buy
+15,604
New +$661K 0.27% 97

Other funds holding BSX

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $144B AUM 22.91% 1-Year Est. Return

Chicago Trust's BSX Position: Q3 2026 in Review

Chicago Trust reduced its Boston Scientific (BSX) stake by 28% in Q3 2026, selling an estimated $466K and leaving 25,994 shares worth $1.13M. The position accounts for 0.15% of the portfolio, ranked #127.

Chicago Trust first reported a position in BSX in Q3 2019 and has held it in 29 quarters since. The position peaked at $3.48M in Q2 2025. 1,064 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Chicago Trust held 25,994 shares of Boston Scientific worth $1.13M as of Q3 2026.
  • Chicago Trust sold 10,070 Boston Scientific shares in Q3 2026, an estimated $466K.
  • Boston Scientific made up 0.15% of Chicago Trust's portfolio in Q3 2026, its #127 holding.
  • Chicago Trust first reported a position in Boston Scientific in Q3 2019 and has held it in 29 quarters since.
  • Chicago Trust's Boston Scientific position peaked at $3.48M in Q2 2025.
  • 1,064 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Chicago Trust's 13F filing for Q3 2026, filed 28 Oct 2026.